Emmanuel Papadakis
Stock Analyst at Deutsche Bank
(3.92)
# 1,924
Out of 4,659 analysts
1252
Total ratings
53.1%
Success rate
3.9%
Average return
Main Sectors:
Stocks Rated by Emmanuel Papadakis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Maintained: Hold | 2,000p | 1,888p | +5.96% | 171 | Aug 19, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Sell | 11,500p | 11,880p | -3.20% | 192 | Aug 19, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 290.00 | kr 292.26 | -0.77% | 159 | Aug 6, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | €900.00 | €865.60 | +3.97% | 35 | Jul 27, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 340.00 | CHF 360.90 | -5.79% | 141 | Jul 24, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Buy | CHF 140.00 | CHF 125.56 | +11.50% | 135 | Jul 22, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Maintained: Buy | kr 285.00 → kr 515.00 | kr 466.00 | +10.52% | 18 | Jul 21, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €100.00 → €95.00 | €77.67 | +22.31% | 143 | Jun 15, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Hold | $43 → $46 | $49.07 | -5.30% | 7 | Jun 4, 2026 | |
| LON: 0MGB Genmab A/S | Maintained: Buy | kr 2,400 → kr 2,250 | kr 2,120 | +6.12% | 23 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 70.00 → CHF 65.00 | CHF 73.40 | -11.44% | 9 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $92.75 | +50.94% | 32 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $45.71 | - | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €285.00 → €295.00 | €217.30 | +35.76% | 25 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $992.99 | - | 2 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €11.00 → €12.00 | €9.76 | n/a | 28 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 → €14.00 | €10.50 | n/a | 12 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €22.00 | €23.82 | n/a | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $44.97 | n/a | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 1.00 | CHF 5.53 | n/a | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $85 → $80 | $62.96 | n/a | 13 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1,225.73 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $14 | $3.95 | n/a | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $7.75 | n/a | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €95.00 → €124.00 | €163.70 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $55.53 | n/a | 3 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $32.96 | n/a | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €44.00 | €52.55 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $127 → $58 | $27.99 | n/a | 2 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $51.15 | n/a | 5 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $19.44 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €80.00 | €48.74 | n/a | 31 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €62.18 → €78.00 | €136.75 | n/a | 2 | Jan 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $154.55 | n/a | 4 | Dec 7, 2018 |
GSK plc
Aug 19, 2026
Maintained: Hold
Price Target: 2,000p
Current: 1,888p
Upside: +5.96%
AstraZeneca PLC
Aug 19, 2026
Maintained: Sell
Price Target: 11,500p
Current: 11,880p
Upside: -3.20%
Novo Nordisk A/S
Aug 6, 2026
Maintained: Hold
Price Target: kr 290.00
Current: kr 292.26
Upside: -0.77%
argenx SE
Jul 27, 2026
Maintained: Buy
Price Target: €900.00
Current: €865.60
Upside: +3.97%
Roche Holding AG
Jul 24, 2026
Maintained: Hold
Price Target: CHF 340.00
Current: CHF 360.90
Upside: -5.79%
Novartis AG
Jul 22, 2026
Maintained: Buy
Price Target: CHF 140.00
Current: CHF 125.56
Upside: +11.50%
Swedish Orphan Biovitrum AB (publ)
Jul 21, 2026
Maintained: Buy
Price Target: kr 285.00 → kr 515.00
Current: kr 466.00
Upside: +10.52%
Sanofi
Jun 15, 2026
Maintained: Buy
Price Target: €100.00 → €95.00
Current: €77.67
Upside: +22.31%
Zealand Pharma A/S
Jun 4, 2026
Maintained: Hold
Price Target: $43 → $46
Current: $49.07
Upside: -5.30%
Genmab A/S
May 11, 2026
Maintained: Buy
Price Target: kr 2,400 → kr 2,250
Current: kr 2,120
Upside: +6.12%
Apr 30, 2026
Maintained: Hold
Price Target: CHF 70.00 → CHF 65.00
Current: CHF 73.40
Upside: -11.44%
Mar 17, 2026
Maintained: Buy
Price Target: $140
Current: $92.75
Upside: +50.94%
Feb 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $45.71
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: €285.00 → €295.00
Current: €217.30
Upside: +35.76%
Sep 11, 2025
Downgraded: Hold
Price Target: n/a
Current: $992.99
Upside: -
Aug 5, 2025
Maintained: Hold
Price Target: €11.00 → €12.00
Current: €9.76
Upside: n/a
Jul 28, 2025
Maintained: Buy
Price Target: €12.00 → €14.00
Current: €10.50
Upside: n/a
Apr 28, 2025
Maintained: Hold
Price Target: €22.00
Current: €23.82
Upside: n/a
Jan 30, 2025
Upgraded: Hold
Price Target: n/a
Current: $44.97
Upside: n/a
Nov 29, 2024
Maintained: Hold
Price Target: CHF 1.00
Current: CHF 5.53
Upside: n/a
Aug 6, 2024
Upgraded: Hold
Price Target: $85 → $80
Current: $62.96
Upside: n/a
Jul 17, 2024
Maintained: Hold
Price Target: n/a
Current: $1,225.73
Upside: n/a
Jul 2, 2024
Reiterated: Hold
Price Target: $8 → $14
Current: $3.95
Upside: n/a
Jun 18, 2024
Upgraded: Hold
Price Target: n/a
Current: $7.75
Upside: n/a
Aug 7, 2023
Maintained: Hold
Price Target: €95.00 → €124.00
Current: €163.70
Upside: n/a
Jan 18, 2023
Downgraded: Sell
Price Target: n/a
Current: $55.53
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $32.96
Upside: n/a
Aug 9, 2022
Maintained: Hold
Price Target: €44.00
Current: €52.55
Upside: n/a
Aug 6, 2021
Downgraded: Hold
Price Target: $127 → $58
Current: $27.99
Upside: n/a
Apr 16, 2021
Maintained: Sell
Price Target: n/a
Current: $51.15
Upside: n/a
Jul 15, 2020
Reiterated: Hold
Price Target: n/a
Current: $19.44
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: €80.00
Current: €48.74
Upside: n/a
Jan 15, 2019
Maintained: Sell
Price Target: €62.18 → €78.00
Current: €136.75
Upside: n/a
Dec 7, 2018
Downgraded: Sell
Price Target: n/a
Current: $154.55
Upside: n/a